Interaction of c-Abl and p73α and their collaboration to induce apoptosis

Nature

Volumn 399, Issue 6738, 1999, Pages 809-812

  Agami, Reuven ^a   Blandino, Giovanni ^a   Oren, Moshe ^a   Shaul, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ONCOPROTEIN; PROTEIN; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ANIMALS; APOPTOSIS; CELL LINE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-ABL; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0033600240     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/21697     Document Type: Article

References (23)

1. Kharbanda, S., Yuan, Z. M., Weichselbaum, R. & Kufe, D. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 17, 3309-3318 (1998).
2. Kaghad, M. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809-819 (1997).
3. Jost, C. A., Marin, M. C. & Kaelin, W. J. p73 is a human p53-related protein that can induce apoptosis. Nature 389, 191-194 (1997).
4. Shi, Y., Alin, K. & Goff, S. P. Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppress v-abl transforming activity. Genes Dev. 9, 2583-2597 (1995).
5. Rickles, R. J. et al. Identification of Src, Fyn, Lyn, Pl3K and Abl SH3 domain ligands using phage display libraries. EMBO J. 13, 5598-5604 (1994).
6. Sparks, A. B., Quilliam, L. A., Thorn, J. M., Der, C. J. & Kay, B. K. Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J. Biol. Chem. 269, 23853-23856 (1994).
7. Dai, Z. & Pendergast, A. M. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev. 9, 2569-2582 (1995).
8. Walker, K. K. & Levine, A. J. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl Acad. Sci. USA 93, 15335-15340 (1996).
9. Sakamuro, D., Sabbatini, P., White, E. & Prendergast, G. C. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15, 887-898 (1997).
10. Venot, C. et al. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific P1G3 gene transactivation and with transcriptional repression. EMBO J. 17, 4668-4679 (1998).
11. Zhu, J., Jiang, J., Zhou, W. & Chen, X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58, 5061-5065 (1998).
12. Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677 (1998).
13. Baskaran, R. et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519 (1997).
14. Shafman, T. et al. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387, 520-523 (1997).
15. Shtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A. & Canaani, E. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47, 277-284 (1986).
16. Kunkel, T. A., Roberts, J. D. & Zakour, R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154, 367-382 (1987).
17. Kanda, T., Sullivan, K. F. & Wahl, G. M. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol. 8, 377-385 (1998).
18. Jiang, W. & Hunter, T. Analysis of cell-cycle profiles in transfected cells using a membrane-targeted GFP. Biotechniques 24, 349-350 (1998).
19. Blandino, G., Levine, A. J. & Oren, M. Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene 18, 477-485 (1999).
20. Honigwachs, J., Faktor, O., Dikstein, R., Shaul, Y. & Laub, O. Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer. J. Virol. 63, 919-924 (1989).
21. Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA 90, 8392-8396 (1993).
22. Canman, C. E. & Lim, D. S. The role of ATM in DNA damage responses and cancer. Oncogene 17, 3301-3308 (1998).
23. Vogt Sionov, R. et al. c-Abl neutralizes the inhibitory effects of Mdm2 on p53. J. Biol. Chem. 274, 8371-8374 (1999).